Search Results

Displaying Results 126-150 of 3800 "'PHD'"

Aug 27, 2026, 12:00 ET BioVid Launches Tumor Worlds™: A Strategic Intelligence System to Decode the Behavioral Logic of Oncology Markets

is no longer just about having the best data; it's about understanding the social and structural reality of the physician," said Meredith Jacobetz, PhD, Senior Director, Oncology Center of Excellence at BioVid. "Tumor Worlds™ lets us build an actionable picture of the world an asset inhabits before that

More news about: BioVid


Aug 27, 2026, 11:41 ET Innovative Professional Development Program for Early Childhood Teachers Helps Tackle Education Disparities in NYC

Dawson-McClure and Brotman, NYU Langone researchers involved in the study include Nicholas Illenberger, PhD; Alexandra Ursache, PhD; R. Gabriela Barajas-Gonzalez, PhD; Dimitra Kamboukos PhD; and Keng-Yen Huang, PhD.About NYU Langone HealthNYU Langone Health is a fully integrated health system

More news about: NYU Langone Health System


Aug 27, 2026, 10:16 ET National Sleep Foundation Assembles Leading Experts to Shape the Future of Drowsy Driving Prevention

The Solutions & Actions Panel will feature these leaders and subject matter experts:Joseph Dzierzewski, PhD, Senior Vice President, Research & Scientific Affairs, National Sleep FoundationJonathan Adkins, Chief Executive Officer, Governors

More news about: National Sleep Foundation


Aug 27, 2026, 09:00 ET Rose BioSolutions Appoints Thomas VanCott, Ph.D., as Head of HemaCare

multimedia:https://www.prnewswire.com/news-releases/rose-biosolutions-appoints-thomas-vancott-phd-as-head-of-hemacare-302861801.htmlSOURCE

More news about: Rose BioSolutions


Aug 27, 2026, 08:36 ET SimX Launches Autonomous Nursing Curricula to Prepare Students for Clinical Practice and Workforce Readiness

experiences."Every nursing student deserves consistent opportunities to practice clinical decision-making in realistic patient care situations," said Kendal Bailey, PhD, RN, CHSE, NE-BC, NPD-BC, CNE, Head of Education and Content at SimX.Together, the two curricula provide a comprehensive pathway from foundational

More news about: SimX


Aug 27, 2026, 08:30 ET Assessing the Use of Non-Human Primates in Translational Research Today, Upcoming Webinar Hosted by Xtalks

growing public and regulatory scrutiny.Join Gourav Roy-Choudhury, PhD, DABT, Senior Director, Toxicology, Franklin Biolabs; Thierry Decelle, DVM, MSc, DipVetLAS, Founder & CEO, DCL Solutions; and Andrea Varrone, MD, PhD, Professor of Molecular PET, Department of Clinical Neuroscience, Karolinska

More news about: Xtalks


Aug 27, 2026, 08:30 ET Advance Clinical Trial Enrichment with Operational Precision Biomarkers, Upcoming Webinar Hosted by Xtalks

biomarkers can improve patient stratification, clinical trial enrichment and trial-ready biomarker implementation.Join Jorge Marques Signes, PhD, Vice President, Laboratory Services,

More news about: Xtalks


Aug 27, 2026, 08:30 ET Modernizing Centrifugation for Cell Separation, Washing and Recovery, Upcoming Webinar Hosted by Xtalks

Register for this webinar to learn how Centrifugation can be reduced to streamline cell separation, washing and recovery workflows.Join Kenta Imai, PhD, Manager Medical Products Group, Business Department Marketing & Business Creation,

More news about: Xtalks


Aug 27, 2026, 08:30 ET Caris Life Sciences Publishes npj Precision Oncology Study Showing AI-Guided Therapy Selection is Predictive of Longer Survival in Patients with Pancreatic Cancer

David Spetzler, MS, PhD, MBA, President of Caris Life Sciences. "Pancreatic AI shows that tumor biology can help guide that decision, identifying patients who may not need the

More news about: Caris Life Sciences


Aug 27, 2026, 08:15 ET Psilera Appoints Neuroscience Veteran Allyson Gage, PhD, as Vice President, Clinical Development to Lead Upcoming Phase 1 Clinical Trial

Allyson Gage, PhD, as Vice President, Clinical Development. In this role, Dr. Gage will oversee the clinical development strategy and operational execution of the

More news about: Psilera, Inc.


Aug 27, 2026, 08:00 ET Four Scientists Awarded $3 Million for High-Impact Research to Advance New Answers for Tau-Driven Diseases

advance understanding of tau biology and inform future diagnostic strategies using novel tools and approaches:Carlo Condello, PhD, University of California, San Francisco (Awarded $750,000): This research aims to reveal the molecular heterogeneity of cell type-specific tau conformers

More news about: The Rainwater Charitable Foundation


Aug 27, 2026, 07:43 ET Chandigarh University Establishes Collaborations with Leading Companies for Internships & Placements across Legal Studies, Liberal Arts and Sciences

also envisages industrial visits, seminars, workshops, expert talks, hackathons and other collaborative activities. Additionally, CU staff may pursue PhD programmes in accordance with University regulations, while CU students may choose a co-supervisor from another organisation, subject to approval by

More news about: Chandigarh University


Aug 27, 2026, 07:00 ET The Farmer's Dog and U.S. Women's No. 1 Jess Pegula Team Up to Help More Rescue Dogs Change Lives

and minimally processed meal plans designed to help dogs live longer, healthier lives. Our on-staff team of Board-Certified Veterinary Nutritionists®, PhD nutritionists, and veterinarians work to develop recipes packed with the nutrients dogs need, while avoiding the downsides of excess processing. Every

More news about: The Farmer's Dog


Aug 27, 2026, 05:01 ET NYU Langone Health Names Sunil Rao, MD, Director of the Leon H. Charney Division of Cardiology and Welcomes Susheel Kodali, MD, to Lead Interventional Cardiology

Alec C. Kimmelman, MD, PhD, dean and CEO of NYU Langone Health. "Dr. Rao has played a central role in strengthening our Interventional Cardiology Program and advancing innovative

More news about: NYU Langone Health


Aug 26, 2026, 16:47 ET Little Rock Selected for Largest American Kidney Patient Meeting

patient advocates and nonprofit organizations. Nationally recognized Arkansas medical leaders are featured prominently including John M. Arthur, PhD, MD; Chief, Nephrology Division; Director, Translational Research Institute; and Director, Junior Faculty Mentored Research Program, Department of Internal

More news about: American Association of Kidney Patients


Aug 26, 2026, 12:03 ET Vesselon Issued Patent and New Data Changes the Therapeutic Index of Antibody-Based Drugs

exposure, representing a promising platform to improve the efficacy and safety profile of antibody-based immunotherapy," stated Pier Paolo Claudio, MD, PhD, Professor of Pharmacology & Toxicology at the University of Mississippi Medical Center and the Cancer Center & Research Institute.Vesselon

More news about: Vesselon Inc.


Aug 26, 2026, 10:38 ET Strengthen Total AAV Potency Assurance with NGS Sequence Analysis, Upcoming Webinar Hosted by Xtalks

assurance can incorporate NGS-based sequence purity testing to support AAV therapy development, validation and commercial release.Join Rebecca Bova, PhD, Senior Scientist, Head of CNAT (Custom NGS Assays Team),

More news about: Xtalks


Aug 26, 2026, 09:07 ET Soris Pain & Vascular Institute Launches Physician-Led Outpatient Platform, Names Dr. Yuji Okuno Founding Physician and Dr. Osman Ahmed Chief Medical Officer

Pain & Vascular Institute today launched its physician-led outpatient platform for musculoskeletal pain and vascular care and named Yuji Okuno, MD, PhD, as Founding Physician and Osman Ahmed, MD, FSIR, FCIRSE, as Chief Medical Officer.

More news about: CUC America Inc


Aug 26, 2026, 08:02 ET Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays

scientific expertise, customer reach and service infrastructure to bring these technologies to a broad customer base," said Daniel Silva Manzano, PhD, Chief Executive Officer of Monod Bio. "This partnership expands the reach of our platform and reinforces the value of our Monod Inside model for

More news about: Sino Biological


Aug 26, 2026, 08:00 ET Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays

scientific expertise, customer reach and service infrastructure to bring these technologies to a broad customer base," said Daniel Silva Manzano, PhD, Chief Executive Officer of Monod Bio. "This partnership expands the reach of our platform and reinforces the value of our Monod Inside model for

More news about: Monod Bio


Aug 26, 2026, 07:54 ET DarwinHealth Introduces Quantum Cancer Biology: A Cell-State Systems Biology Framework for Precision Oncology

new perspective led by Dr. Andrea Califano and Dr. Kenneth P. Olive, driven by first author Dr. Pasquale Laise, PhD, alongside co-first authors Mikko Turunen, PhD, and Alvaro Curiel-Garcia, PhD.The study, conducted at Columbia University, presents original research findings and argues that the next

More news about: DarwinHealth


Aug 26, 2026, 07:00 ET Vivace Therapeutics Strengthens Leadership Team as It Prepares to Advance VT3989, the First TEAD Inhibitor to enter Phase 3 Clinical Trials, as the Leading Treatment for Mesothelioma

Craig Gibbs, PhD, MBA, appointed President and Chief Executive OfficerEllen Lubman, MBA, joins as Chief Business and Strategy OfficerOncology veteran Tim Clackson, PhD, appointed to the Board of Directors FDA

More news about: Vivace Therapeutics, Inc.


Aug 26, 2026, 06:37 ET Commercialization Roadmap Validated with Three-digit Million-dollar Revenue: Insilico Medicine Announces Interim Results for the First Half of 2026

and will initiate clinical studies.Garutadustat (ISM5411): In January, Insilico Medicine announced that Garutadustat, an innovative PHD inhibitor with gut-restricted properties, successfully completed first-patient dosing in the Phase IIa BETHESDA clinical trial for the treatment of inflammatory

More news about: Insilico Medicine


Aug 26, 2026, 06:00 ET The Crime Before the Crime

to think awareness alone is going to change behavior is naive. Different security measures are needed to address this risk," said Melissa Moore, PhD, a social and behavioral scientist at YouGov. Americans say one thing and do another at the door A majority, 53%, say they would

More news about: Alcatraz


Aug 25, 2026, 17:13 ET Accrete Climbs Into the Top Tier of the 2026 Inc. 5000 Fastest Growing Private Companies

advisors include General (Ret.) Paul M. Nakasone, General (Ret.) Stanley A. McChrystal, Lieutenant General (Ret.) Daniel L. Karbler, and Andy Hock, PhD, Chief Strategy Officer of Cerebras Systems."I expect Accrete to keep showing up on this list because we've built the foundation and it compounds,

More news about: Accrete


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.